4//SEC Filing
ANADYS PHARMACEUTICALS INC 4
Accession 0001209191-11-052489
CIK 0001128495operating
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:54 PM ET
Size
8.5 KB
Accession
0001209191-11-052489
Insider Transaction Report
Form 4
QVT Fund LP
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2011-10-20$3.68/sh−5,252,700$19,329,936→ 5,517,854 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.) - Sale
Common Stock, $0.001 par value
2011-10-21$3.68/sh−364,918$1,342,898→ 5,152,936 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.)
QVT Associates GP LLC
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2011-10-21$3.68/sh−364,918$1,342,898→ 5,152,936 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.) - Sale
Common Stock, $0.001 par value
2011-10-20$3.68/sh−5,252,700$19,329,936→ 5,517,854 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.)
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeoperating
Related Parties
1- filerCIK 0001128495
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:54 PM ET
- Size
- 8.5 KB